Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$337,012,405
-$397,412,775 QoQ
Shares Held
4,689,847
-19.7% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#14
of 1,408 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORGES BANK holds $2,351,821,288 across 19 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,299,753 | $1,094,315,631 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
694,753 | $376,438,017 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
4,689,847 | $337,012,405 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
973,880 | $164,137,735 | |
| 5 | ALKS |
Alkermes plc.
|
2,156,814 | $113,017,053 | |
| 6 | HLN |
Haleon plc
|
7,175,000 | $66,942,750 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
586,845 | $65,104,584 | |
| 8 | VTRS |
Viatris Inc
|
3,822,744 | $60,705,174 |
All Filings in ZTS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,012,405 | 4,689,847 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $734,425,180 | 5,837,110 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $809,491,380 | 5,190,711 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $838,591,593 | 5,093,177 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $824,320,710 | 5,059,355 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $970,344,414 | 4,966,447 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $868,005,198 | 5,006,952 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $854,354,657 | 5,049,079 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $980,646,068 | 4,968,567 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $843,130,393 | 4,846,134 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $918,580,194 | 5,334,070 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $886,064,311 | 5,323,626 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $745,860,802 | 5,089,463 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $712,659,941 | 4,805,853 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $805,460,210 | 4,685,905 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $881,408,368 | 4,673,675 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $1,067,880,892 | 4,376,023 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $844,917,664 | 4,352,105 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $836,789,758 | 4,490,179 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $723,070,837 | 4,591,509 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $763,473,842 | 4,613,135 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $736,390,790 | 4,452,989 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $583,514,127 | 4,257,984 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $534,190,673 | 4,538,964 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||